Catalio Capital closes more than 400 million dollars Fourth Fund

Catalio Capital Management Declared today Close his fourth fund from 400 million dollars, As I mentioned for the first time by Bloomberg. The fund will continue the company’s thesis to support health care companies and biotechnology.

The company was founded in 2020 and has provided more than 100 investments, according to Cook. Catalio’s IV, in particular, has already supported 16 companies, including the PinkDX Diagnostic Company and DROG Discovery Superluminal Company.

The company previously raised the III fund 381 million dollars in 2020 and a $ 100 million fund in 2019, for each book.

The biotechnology market, in particular, was not fortified from the project’s shrinkage last year, followed by high interest rates and the cooler public subscription market. The market was generally raised only $ 12 billion in the past year, a sharp decrease from its peak of $ 152.3 billion in 2023, according to Bloomberg.